P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P17252 |
KPCA_HUMAN |
Lung cancer [ICD-11: 2C25] |
P17252 |
KPCA_HUMAN |
Muscular atrophy [ICD-11: 8B61] |
P17252 |
KPCA_HUMAN |
Transplant rejection [ICD-11: NE84] |
P17252 |
KPCA_HUMAN |
Nephritic syndrome [ICD-11: GB40] |
P17252 |
KPCA_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05771 |
KPCB_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05771 |
KPCB_HUMAN |
Central nervous system disease [ICD-11: 8A04-8D87] |
P05771 |
KPCB_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P05771 |
KPCB_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P05771 |
KPCB_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P05771 |
KPCB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05771 |
KPCB_HUMAN |
Transplant rejection [ICD-11: NE84] |
P05771 |
KPCB_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P05771 |
KPCB_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05771 |
KPCB_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q04759 |
KPCT_HUMAN |
Transplant rejection [ICD-11: NE84] |
Q04759 |
KPCT_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q04759 |
KPCT_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q04759 |
KPCT_HUMAN |
Transplant rejection [ICD-11: NE84] |
Q04759 |
KPCT_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q04759 |
KPCT_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q04759 |
KPCT_HUMAN |
Transplant rejection [ICD-11: NE84] |
Q04759 |
KPCT_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q04759 |
KPCT_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q04759 |
KPCT_HUMAN |
Transplant rejection [ICD-11: NE84] |
Q04759 |
KPCT_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q04759 |
KPCT_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q04759 |
KPCT_HUMAN |
Transplant rejection [ICD-11: NE84] |
Q04759 |
KPCT_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q04759 |
KPCT_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q05655 |
KPCD_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05129 |
KPCG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P05129 |
KPCG_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P05129 |
KPCG_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P05129 |
KPCG_HUMAN |
Mastocytosis [ICD-11: 2A21] |
P05129 |
KPCG_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05129 |
KPCG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P05129 |
KPCG_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P05129 |
KPCG_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P05129 |
KPCG_HUMAN |
Mastocytosis [ICD-11: 2A21] |
P05129 |
KPCG_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05129 |
KPCG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P05129 |
KPCG_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P05129 |
KPCG_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P05129 |
KPCG_HUMAN |
Mastocytosis [ICD-11: 2A21] |
P05129 |
KPCG_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05129 |
KPCG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P05129 |
KPCG_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P05129 |
KPCG_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P05129 |
KPCG_HUMAN |
Mastocytosis [ICD-11: 2A21] |
P05129 |
KPCG_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05129 |
KPCG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P05129 |
KPCG_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P05129 |
KPCG_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P05129 |
KPCG_HUMAN |
Mastocytosis [ICD-11: 2A21] |
P05129 |
KPCG_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P05129 |
KPCG_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P05129 |
KPCG_HUMAN |
Chronic myelomonocytic leukaemia [ICD-11: 2A40] |
P05129 |
KPCG_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P05129 |
KPCG_HUMAN |
Mastocytosis [ICD-11: 2A21] |
P05129 |
KPCG_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
Q02156 |
KPCE_HUMAN |
Anxiety disorder [ICD-11: 6B00-6B0Z] |
Q02156 |
KPCE_HUMAN |
Liver vascular disorder [ICD-11: DB98] |
Q02156 |
KPCE_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
Q02156 |
KPCE_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
Q02156 |
KPCE_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
Q02156 |
KPCE_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
P24723 |
KPCL_HUMAN |
Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |